CSIMarket Company Name, Ticker, Suppliers, else..
 
Conformis inc   (CFMS)
Other Ticker:  
 
 
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 7
 Employees 200
 Revenues (TTM) (Millions $) 57
 Net Income (TTM) (Millions $) -42
 Cash Flow (TTM) (Millions $) -46
 Capital Exp. (TTM) (Millions $) 2

Conformis Inc
Conformis Inc. is a medical technology company focused on developing and commercializing custom orthopedic implants and instrumentation. The company is known for its innovative approach to knee and hip replacements, utilizing 3D printing technology to create personalized implants tailored to each individual patient. Conformis aims to improve patient outcomes and accelerate the recovery process by providing custom-fit implants that closely match the patient's unique anatomy. The company also offers software tools and surgical planning solutions to assist surgeons in preoperative planning and implant design.


   Company Address: 600 Technology Park Drive Billerica 1821 MA
   Company Phone Number: 345-9001   Stock Exchange / Ticker: CFMS


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ENOV      % 
EW      % 
MDT      % 
SYK      % 
TFX      % 
ZBH      % 
• View Complete Report
   



Conformis Inc

Conformis Inc Hit Hard by Massive Sales Downturn, Suffers Staggering Shortfall Ending Fiscal Time-Frame in June 2023!



In the fiscal year ending on June 30, 2023, Conformis Inc (CFMS) witnessed a significant increase in deficit per share compared to the previous year. The company reported a deficit per share of $-1.78, a notable rise from $-0.09 in the previous fiscal year. Additionally, the deficit surged from $-1.32 per share in the preceding reporting period.
One of the major concerns for investors is the decline in revenue, which fell by -14.855% to $13.02 million, in contrast to $15.30 million in the comparable reporting period last year. Although the revenue did see a small sequential increase of 1.449% from $12.84 million, this was overshadowed by the slump in comparison to the rest of the Medical Equipment & Supplies industry, which experienced a top-line growth during the same period.
Conformis Inc

CFMS Records Exponential Losses as First Quarter Comes to a Close in 2023

Conformis Inc, a medical devices company, recently released its first-quarter financial report for 2023. The report shows the company experienced a shortfall per share of $-1.32 in the first quarter of 2023, which is a significant increase from the $-0.09 per share shortfall reported a year earlier. Additionally, the shortfall grew from $-0.02 per share from the preceding quarter.
On the revenue side, the company reported a respectable decrease of -17.452% to $12.84 million from $15.55 million in the comparable quarter a year before. Sequentially, the revenue fell by -26.309% from $17.42 million. These figures suggest that the company is struggling to maintain its revenue stream, which could indicate problems in its operations.









Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com